カテゴリー： 世界, 医療/バイオ, QYResearch

脳卒中診断薬の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Stroke Diagnostics Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09290）・商品コード：QY22JLX09290
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥735,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,102,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,470,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、脳卒中診断薬のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に脳卒中診断薬の世界市場のxxx％を占める「ソフトウエア」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「虚血性脳卒中」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
脳卒中診断薬の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの脳卒中診断薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

脳卒中診断薬のグローバル主要企業には、Abbott Laboratories Ltd.、Medtronic(Covidien)、General Electric Company(GE Healthcare)、Hitachi, Ltd.、Johnson & Johnson、Penumbra, Inc.、Koninklijke Philips N.V.、Siemens(Siemens International GmbH)、Stryker Corporation (Concentric Medical, Inc.)、Canon Medical Systems Corporation、Nihon Kohden Corporation、Sense Neuro Diagnostics、Forest Devices、Brainomix、Jan Medical、RapidAI、Viz.aiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

脳卒中診断薬市場は、種類と用途によって区分されます。世界の脳卒中診断薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ソフトウエア、ハードウエア

【用途別セグメント】
虚血性脳卒中、出血性脳卒中、一過性脳虚血発作

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 脳卒中診断薬製品概要
- 種類別市場（ソフトウエア、ハードウエア）
- 用途別市場（虚血性脳卒中、出血性脳卒中、一過性脳虚血発作）
- 調査の目的
・エグゼクティブサマリー
- 世界の脳卒中診断薬販売量予測2017-2028
- 世界の脳卒中診断薬売上予測2017-2028
- 脳卒中診断薬の地域別販売量
- 脳卒中診断薬の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別脳卒中診断薬販売量
- 主要メーカー別脳卒中診断薬売上
- 主要メーカー別脳卒中診断薬価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ソフトウエア、ハードウエア）
- 脳卒中診断薬の種類別販売量
- 脳卒中診断薬の種類別売上
- 脳卒中診断薬の種類別価格
・用途別市場規模（虚血性脳卒中、出血性脳卒中、一過性脳虚血発作）
- 脳卒中診断薬の用途別販売量
- 脳卒中診断薬の用途別売上
- 脳卒中診断薬の用途別価格
・北米市場
- 北米の脳卒中診断薬市場規模（種類別、用途別）
- 主要国別の脳卒中診断薬市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの脳卒中診断薬市場規模（種類別、用途別）
- 主要国別の脳卒中診断薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の脳卒中診断薬市場規模（種類別、用途別）
- 主要国別の脳卒中診断薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の脳卒中診断薬市場規模（種類別、用途別）
- 主要国別の脳卒中診断薬市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの脳卒中診断薬市場規模（種類別、用途別）
- 主要国別の脳卒中診断薬市場規模（トルコ、サウジアラビア）
・企業情報
Abbott Laboratories Ltd.、Medtronic(Covidien)、General Electric Company(GE Healthcare)、Hitachi, Ltd.、Johnson & Johnson、Penumbra, Inc.、Koninklijke Philips N.V.、Siemens(Siemens International GmbH)、Stryker Corporation (Concentric Medical, Inc.)、Canon Medical Systems Corporation、Nihon Kohden Corporation、Sense Neuro Diagnostics、Forest Devices、Brainomix、Jan Medical、RapidAI、Viz.ai
・産業チェーン及び販売チャネル分析
- 脳卒中診断薬の産業チェーン分析
- 脳卒中診断薬の原材料
- 脳卒中診断薬の生産プロセス
- 脳卒中診断薬の販売及びマーケティング
- 脳卒中診断薬の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 脳卒中診断薬の産業動向
- 脳卒中診断薬のマーケットドライバー
- 脳卒中診断薬の課題
- 脳卒中診断薬の阻害要因
・主な調査結果

Market Analysis and Insights: Global Stroke Diagnostics Market
The global Stroke Diagnostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Software accounting for % of the Stroke Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Ischemic Stroke segment is altered to an % CAGR throughout this forecast period.
China Stroke Diagnostics market size is valued at US$ million in 2021, while the North America and Europe Stroke Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Stroke Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stroke Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stroke Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stroke Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stroke Diagnostics market.
Global Stroke Diagnostics Scope and Market Size
Stroke Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Stroke Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Software
Hardware
Segment by Application
Ischemic Stroke
Hemorrhagic Stroke
Transient Ischemic Attack
By Company
Abbott Laboratories Ltd.
Medtronic(Covidien)
General Electric Company(GE Healthcare)
Hitachi, Ltd.
Johnson & Johnson
Penumbra, Inc.
Koninklijke Philips N.V.
Siemens(Siemens International GmbH)
Stryker Corporation (Concentric Medical, Inc.)
Canon Medical Systems Corporation
Nihon Kohden Corporation
Sense Neuro Diagnostics
Forest Devices
Brainomix
Jan Medical
RapidAI
Viz.ai
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stroke Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Software
1.2.3 Hardware
1.3 Market by Application
1.3.1 Global Stroke Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ischemic Stroke
1.3.3 Hemorrhagic Stroke
1.3.4 Transient Ischemic Attack
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stroke Diagnostics Market Perspective (2017-2028)
2.2 Stroke Diagnostics Growth Trends by Region
2.2.1 Stroke Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Stroke Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Stroke Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Stroke Diagnostics Market Dynamics
2.3.1 Stroke Diagnostics Industry Trends
2.3.2 Stroke Diagnostics Market Drivers
2.3.3 Stroke Diagnostics Market Challenges
2.3.4 Stroke Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stroke Diagnostics Players by Revenue
3.1.1 Global Top Stroke Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Stroke Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Stroke Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stroke Diagnostics Revenue
3.4 Global Stroke Diagnostics Market Concentration Ratio
3.4.1 Global Stroke Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stroke Diagnostics Revenue in 2021
3.5 Stroke Diagnostics Key Players Head office and Area Served
3.6 Key Players Stroke Diagnostics Product Solution and Service
3.7 Date of Enter into Stroke Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stroke Diagnostics Breakdown Data by Type
4.1 Global Stroke Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Stroke Diagnostics Forecasted Market Size by Type (2023-2028)
5 Stroke Diagnostics Breakdown Data by Application
5.1 Global Stroke Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Stroke Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Stroke Diagnostics Market Size (2017-2028)
6.2 North America Stroke Diagnostics Market Size by Type
6.2.1 North America Stroke Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Stroke Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Stroke Diagnostics Market Share by Type (2017-2028)
6.3 North America Stroke Diagnostics Market Size by Application
6.3.1 North America Stroke Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Stroke Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Stroke Diagnostics Market Share by Application (2017-2028)
6.4 North America Stroke Diagnostics Market Size by Country
6.4.1 North America Stroke Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Stroke Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Stroke Diagnostics Market Size (2017-2028)
7.2 Europe Stroke Diagnostics Market Size by Type
7.2.1 Europe Stroke Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Stroke Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Stroke Diagnostics Market Share by Type (2017-2028)
7.3 Europe Stroke Diagnostics Market Size by Application
7.3.1 Europe Stroke Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Stroke Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Stroke Diagnostics Market Share by Application (2017-2028)
7.4 Europe Stroke Diagnostics Market Size by Country
7.4.1 Europe Stroke Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Stroke Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stroke Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Stroke Diagnostics Market Size by Type
8.2.1 Asia-Pacific Stroke Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Stroke Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Stroke Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Stroke Diagnostics Market Size by Application
8.3.1 Asia-Pacific Stroke Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Stroke Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Stroke Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Stroke Diagnostics Market Size by Region
8.4.1 Asia-Pacific Stroke Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Stroke Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stroke Diagnostics Market Size (2017-2028)
9.2 Latin America Stroke Diagnostics Market Size by Type
9.2.1 Latin America Stroke Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Stroke Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Stroke Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Stroke Diagnostics Market Size by Application
9.3.1 Latin America Stroke Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Stroke Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Stroke Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Stroke Diagnostics Market Size by Country
9.4.1 Latin America Stroke Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Stroke Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stroke Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Stroke Diagnostics Market Size by Type
10.2.1 Middle East & Africa Stroke Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Stroke Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Stroke Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Stroke Diagnostics Market Size by Application
10.3.1 Middle East & Africa Stroke Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Stroke Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Stroke Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Stroke Diagnostics Market Size by Country
10.4.1 Middle East & Africa Stroke Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Stroke Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories Ltd.
11.1.1 Abbott Laboratories Ltd. Company Details
11.1.2 Abbott Laboratories Ltd. Business Overview
11.1.3 Abbott Laboratories Ltd. Stroke Diagnostics Introduction
11.1.4 Abbott Laboratories Ltd. Revenue in Stroke Diagnostics Business (2017-2022)
11.1.5 Abbott Laboratories Ltd. Recent Developments
11.2 Medtronic(Covidien)
11.2.1 Medtronic(Covidien) Company Details
11.2.2 Medtronic(Covidien) Business Overview
11.2.3 Medtronic(Covidien) Stroke Diagnostics Introduction
11.2.4 Medtronic(Covidien) Revenue in Stroke Diagnostics Business (2017-2022)
11.2.5 Medtronic(Covidien) Recent Developments
11.3 General Electric Company(GE Healthcare)
11.3.1 General Electric Company(GE Healthcare) Company Details
11.3.2 General Electric Company(GE Healthcare) Business Overview
11.3.3 General Electric Company(GE Healthcare) Stroke Diagnostics Introduction
11.3.4 General Electric Company(GE Healthcare) Revenue in Stroke Diagnostics Business (2017-2022)
11.3.5 General Electric Company(GE Healthcare) Recent Developments
11.4 Hitachi, Ltd.
11.4.1 Hitachi, Ltd. Company Details
11.4.2 Hitachi, Ltd. Business Overview
11.4.3 Hitachi, Ltd. Stroke Diagnostics Introduction
11.4.4 Hitachi, Ltd. Revenue in Stroke Diagnostics Business (2017-2022)
11.4.5 Hitachi, Ltd. Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Stroke Diagnostics Introduction
11.5.4 Johnson & Johnson Revenue in Stroke Diagnostics Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Penumbra, Inc.
11.6.1 Penumbra, Inc. Company Details
11.6.2 Penumbra, Inc. Business Overview
11.6.3 Penumbra, Inc. Stroke Diagnostics Introduction
11.6.4 Penumbra, Inc. Revenue in Stroke Diagnostics Business (2017-2022)
11.6.5 Penumbra, Inc. Recent Developments
11.7 Koninklijke Philips N.V.
11.7.1 Koninklijke Philips N.V. Company Details
11.7.2 Koninklijke Philips N.V. Business Overview
11.7.3 Koninklijke Philips N.V. Stroke Diagnostics Introduction
11.7.4 Koninklijke Philips N.V. Revenue in Stroke Diagnostics Business (2017-2022)
11.7.5 Koninklijke Philips N.V. Recent Developments
11.8 Siemens(Siemens International GmbH)
11.8.1 Siemens(Siemens International GmbH) Company Details
11.8.2 Siemens(Siemens International GmbH) Business Overview
11.8.3 Siemens(Siemens International GmbH) Stroke Diagnostics Introduction
11.8.4 Siemens(Siemens International GmbH) Revenue in Stroke Diagnostics Business (2017-2022)
11.8.5 Siemens(Siemens International GmbH) Recent Developments
11.9 Stryker Corporation (Concentric Medical, Inc.)
11.9.1 Stryker Corporation (Concentric Medical, Inc.) Company Details
11.9.2 Stryker Corporation (Concentric Medical, Inc.) Business Overview
11.9.3 Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Introduction
11.9.4 Stryker Corporation (Concentric Medical, Inc.) Revenue in Stroke Diagnostics Business (2017-2022)
11.9.5 Stryker Corporation (Concentric Medical, Inc.) Recent Developments
11.10 Canon Medical Systems Corporation
11.10.1 Canon Medical Systems Corporation Company Details
11.10.2 Canon Medical Systems Corporation Business Overview
11.10.3 Canon Medical Systems Corporation Stroke Diagnostics Introduction
11.10.4 Canon Medical Systems Corporation Revenue in Stroke Diagnostics Business (2017-2022)
11.10.5 Canon Medical Systems Corporation Recent Developments
11.11 Nihon Kohden Corporation
11.11.1 Nihon Kohden Corporation Company Details
11.11.2 Nihon Kohden Corporation Business Overview
11.11.3 Nihon Kohden Corporation Stroke Diagnostics Introduction
11.11.4 Nihon Kohden Corporation Revenue in Stroke Diagnostics Business (2017-2022)
11.11.5 Nihon Kohden Corporation Recent Developments
11.12 Sense Neuro Diagnostics
11.12.1 Sense Neuro Diagnostics Company Details
11.12.2 Sense Neuro Diagnostics Business Overview
11.12.3 Sense Neuro Diagnostics Stroke Diagnostics Introduction
11.12.4 Sense Neuro Diagnostics Revenue in Stroke Diagnostics Business (2017-2022)
11.12.5 Sense Neuro Diagnostics Recent Developments
11.13 Forest Devices
11.13.1 Forest Devices Company Details
11.13.2 Forest Devices Business Overview
11.13.3 Forest Devices Stroke Diagnostics Introduction
11.13.4 Forest Devices Revenue in Stroke Diagnostics Business (2017-2022)
11.13.5 Forest Devices Recent Developments
11.14 Brainomix
11.14.1 Brainomix Company Details
11.14.2 Brainomix Business Overview
11.14.3 Brainomix Stroke Diagnostics Introduction
11.14.4 Brainomix Revenue in Stroke Diagnostics Business (2017-2022)
11.14.5 Brainomix Recent Developments
11.15 Jan Medical
11.15.1 Jan Medical Company Details
11.15.2 Jan Medical Business Overview
11.15.3 Jan Medical Stroke Diagnostics Introduction
11.15.4 Jan Medical Revenue in Stroke Diagnostics Business (2017-2022)
11.15.5 Jan Medical Recent Developments
11.16 RapidAI
11.16.1 RapidAI Company Details
11.16.2 RapidAI Business Overview
11.16.3 RapidAI Stroke Diagnostics Introduction
11.16.4 RapidAI Revenue in Stroke Diagnostics Business (2017-2022)
11.16.5 RapidAI Recent Developments
11.17 Viz.ai
11.17.1 Viz.ai Company Details
11.17.2 Viz.ai Business Overview
11.17.3 Viz.ai Stroke Diagnostics Introduction
11.17.4 Viz.ai Revenue in Stroke Diagnostics Business (2017-2022)
11.17.5 Viz.ai Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Stroke Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Software
Table 3. Key Players of Hardware
Table 4. Global Stroke Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Stroke Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Stroke Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Stroke Diagnostics Market Share by Region (2017-2022)
Table 8. Global Stroke Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Stroke Diagnostics Market Share by Region (2023-2028)
Table 10. Stroke Diagnostics Market Trends
Table 11. Stroke Diagnostics Market Drivers
Table 12. Stroke Diagnostics Market Challenges
Table 13. Stroke Diagnostics Market Restraints
Table 14. Global Stroke Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Stroke Diagnostics Revenue Share by Players (2017-2022)
Table 16. Global Top Stroke Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics as of 2021)
Table 17. Ranking of Global Top Stroke Diagnostics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Stroke Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stroke Diagnostics Product Solution and Service
Table 21. Date of Enter into Stroke Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stroke Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Stroke Diagnostics Revenue Market Share by Type (2017-2022)
Table 25. Global Stroke Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Stroke Diagnostics Revenue Market Share by Type (2023-2028)
Table 27. Global Stroke Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Stroke Diagnostics Revenue Share by Application (2017-2022)
Table 29. Global Stroke Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Stroke Diagnostics Revenue Share by Application (2023-2028)
Table 31. North America Stroke Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Stroke Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Stroke Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Stroke Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Stroke Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Stroke Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Stroke Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Stroke Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Stroke Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Stroke Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Stroke Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Stroke Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Stroke Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Stroke Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Stroke Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Stroke Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Stroke Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Stroke Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Stroke Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Stroke Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Stroke Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Stroke Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Stroke Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Stroke Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Stroke Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Stroke Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Stroke Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Stroke Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Stroke Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Stroke Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Abbott Laboratories Ltd. Company Details
Table 62. Abbott Laboratories Ltd. Business Overview
Table 63. Abbott Laboratories Ltd. Stroke Diagnostics Product
Table 64. Abbott Laboratories Ltd. Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 65. Abbott Laboratories Ltd. Recent Developments
Table 66. Medtronic(Covidien) Company Details
Table 67. Medtronic(Covidien) Business Overview
Table 68. Medtronic(Covidien) Stroke Diagnostics Product
Table 69. Medtronic(Covidien) Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 70. Medtronic(Covidien) Recent Developments
Table 71. General Electric Company(GE Healthcare) Company Details
Table 72. General Electric Company(GE Healthcare) Business Overview
Table 73. General Electric Company(GE Healthcare) Stroke Diagnostics Product
Table 74. General Electric Company(GE Healthcare) Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 75. General Electric Company(GE Healthcare) Recent Developments
Table 76. Hitachi, Ltd. Company Details
Table 77. Hitachi, Ltd. Business Overview
Table 78. Hitachi, Ltd. Stroke Diagnostics Product
Table 79. Hitachi, Ltd. Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 80. Hitachi, Ltd. Recent Developments
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Stroke Diagnostics Product
Table 84. Johnson & Johnson Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 85. Johnson & Johnson Recent Developments
Table 86. Penumbra, Inc. Company Details
Table 87. Penumbra, Inc. Business Overview
Table 88. Penumbra, Inc. Stroke Diagnostics Product
Table 89. Penumbra, Inc. Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 90. Penumbra, Inc. Recent Developments
Table 91. Koninklijke Philips N.V. Company Details
Table 92. Koninklijke Philips N.V. Business Overview
Table 93. Koninklijke Philips N.V. Stroke Diagnostics Product
Table 94. Koninklijke Philips N.V. Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 95. Koninklijke Philips N.V. Recent Developments
Table 96. Siemens(Siemens International GmbH) Company Details
Table 97. Siemens(Siemens International GmbH) Business Overview
Table 98. Siemens(Siemens International GmbH) Stroke Diagnostics Product
Table 99. Siemens(Siemens International GmbH) Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 100. Siemens(Siemens International GmbH) Recent Developments
Table 101. Stryker Corporation (Concentric Medical, Inc.) Company Details
Table 102. Stryker Corporation (Concentric Medical, Inc.) Business Overview
Table 103. Stryker Corporation (Concentric Medical, Inc.) Stroke Diagnostics Product
Table 104. Stryker Corporation (Concentric Medical, Inc.) Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 105. Stryker Corporation (Concentric Medical, Inc.) Recent Developments
Table 106. Canon Medical Systems Corporation Company Details
Table 107. Canon Medical Systems Corporation Business Overview
Table 108. Canon Medical Systems Corporation Stroke Diagnostics Product
Table 109. Canon Medical Systems Corporation Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 110. Canon Medical Systems Corporation Recent Developments
Table 111. Nihon Kohden Corporation Company Details
Table 112. Nihon Kohden Corporation Business Overview
Table 113. Nihon Kohden Corporation Stroke Diagnostics Product
Table 114. Nihon Kohden Corporation Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 115. Nihon Kohden Corporation Recent Developments
Table 116. Sense Neuro Diagnostics Company Details
Table 117. Sense Neuro Diagnostics Business Overview
Table 118. Sense Neuro Diagnostics Stroke Diagnostics Product
Table 119. Sense Neuro Diagnostics Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 120. Sense Neuro Diagnostics Recent Developments
Table 121. Forest Devices Company Details
Table 122. Forest Devices Business Overview
Table 123. Forest Devices Stroke Diagnostics Product
Table 124. Forest Devices Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 125. Forest Devices Recent Developments
Table 126. Brainomix Company Details
Table 127. Brainomix Business Overview
Table 128. Brainomix Stroke Diagnostics Product
Table 129. Brainomix Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 130. Brainomix Recent Developments
Table 131. Jan Medical Company Details
Table 132. Jan Medical Business Overview
Table 133. Jan Medical Stroke Diagnostics Product
Table 134. Jan Medical Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 135. Jan Medical Recent Developments
Table 136. RapidAI Company Details
Table 137. RapidAI Business Overview
Table 138. RapidAI Stroke Diagnostics Product
Table 139. RapidAI Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 140. RapidAI Recent Developments
Table 141. Viz.ai Company Details
Table 142. Viz.ai Business Overview
Table 143. Viz.ai Stroke Diagnostics Product
Table 144. Viz.ai Revenue in Stroke Diagnostics Business (2017-2022) & (US$ Million)
Table 145. Viz.ai Recent Developments
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stroke Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Software Features
Figure 3. Hardware Features
Figure 4. Global Stroke Diagnostics Market Share by Application: 2021 VS 2028
Figure 5. Ischemic Stroke Case Studies
Figure 6. Hemorrhagic Stroke Case Studies
Figure 7. Transient Ischemic Attack Case Studies
Figure 8. Stroke Diagnostics Report Years Considered
Figure 9. Global Stroke Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Stroke Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Stroke Diagnostics Market Share by Region: 2021 VS 2028
Figure 12. Global Stroke Diagnostics Market Share by Players in 2021
Figure 13. Global Top Stroke Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Stroke Diagnostics Revenue in 2021
Figure 15. North America Stroke Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Stroke Diagnostics Market Size Market Share by Type (2017-2028)
Figure 17. North America Stroke Diagnostics Market Size Market Share by Application (2017-2028)
Figure 18. North America Stroke Diagnostics Market Size Share by Country (2017-2028)
Figure 19. United States Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Stroke Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Stroke Diagnostics Market Size Market Share by Type (2017-2028)
Figure 23. Europe Stroke Diagnostics Market Size Market Share by Application (2017-2028)
Figure 24. Europe Stroke Diagnostics Market Size Share by Country (2017-2028)
Figure 25. Germany Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Stroke Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Stroke Diagnostics Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Stroke Diagnostics Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Stroke Diagnostics Market Size Share by Region (2017-2028)
Figure 35. China Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Stroke Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Stroke Diagnostics Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Stroke Diagnostics Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Stroke Diagnostics Market Size Share by Country (2017-2028)
Figure 45. Mexico Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Stroke Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Stroke Diagnostics Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Stroke Diagnostics Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Stroke Diagnostics Market Size Share by Country (2017-2028)
Figure 51. Turkey Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Stroke Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Abbott Laboratories Ltd. Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 55. Medtronic(Covidien) Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 56. General Electric Company(GE Healthcare) Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 57. Hitachi, Ltd. Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 58. Johnson & Johnson Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 59. Penumbra, Inc. Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 60. Koninklijke Philips N.V. Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 61. Siemens(Siemens International GmbH) Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 62. Stryker Corporation (Concentric Medical, Inc.) Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 63. Canon Medical Systems Corporation Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 64. Nihon Kohden Corporation Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 65. Sense Neuro Diagnostics Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 66. Forest Devices Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 67. Brainomix Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 68. Jan Medical Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 69. RapidAI Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 70. Viz.ai Revenue Growth Rate in Stroke Diagnostics Business (2017-2022)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed


★調査レポート[脳卒中診断薬の世界市場インサイト・予測（～2028年）] (コード：QY22JLX09290)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳卒中診断薬の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 脳卒中治療の世界市場インサイト・予測（～2028年）
  • 診断用人工知能（AI）の世界市場インサイト・予測（～2028年）
  • アレルギー診断・検査の世界市場インサイト・予測（～2028年）
  • アレルギー診断試薬の世界市場インサイト・予測（～2028年）
  • アレルギー診断試薬・キットの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆